The FDA’s approval of Vyleesi (bremelanotide) offers women a new treatment option for hypoactive sexual desire disorder (HSDD). This injectable medication works differently than other treatments, targeting brain receptors to increase sexual desire.
Vyleesi isn’t a direct equivalent to Viagra; it doesn’t work by increasing blood flow. Instead, it impacts neurotransmitters associated with sexual response. Expect results within 20-30 minutes of injection, with effects lasting around 2-3 hours.
Before using Vyleesi, discuss potential side effects with your doctor. Common side effects include nausea, flushing, and vomiting. More serious, though rare, reactions include fainting. Your physician will assess your overall health and discuss potential medication interactions.
Unlike oral medications, Vyleesi requires an injection. Patients should carefully follow the prescribed dosage and administration instructions. Regular monitoring by your healthcare provider is recommended to track efficacy and adjust treatment if needed.
Vyleesi offers a targeted approach to HSDD treatment, providing an alternative for women who haven’t found success with other therapies. Consult your doctor to determine if Vyleesi is the right option for you.
